# US 2016/0354616 A1 · Scintillation array apparatus and method of use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0354616 A1
- Document ID: US20160354616A1
- Status: Published application
- Kind: A1
- Application number: 15/239,773
- Filed: 2016-08-17
- Published: 2016-12-08
- Earliest claimed: 2008-05-22
- Inventors: W. Davis Lee; Mark R Amato; Stephen L. Spotts; James P. Bennett
- Web page: https://patentgrep.com/patent/US20160354616A1

## CPC

- A61N 5/1069: {Target adjustment, e.g. moving the patient support}
- A61B 6/03: Computed tomography [CT]
- A61B 6/032: {Transmission computed tomography [CT]}
- A61B 6/4014: {arranged in multiple source-detector units}
- A61B 6/4092: {for producing synchrotron radiation}
- A61B 6/4258: {for detecting non x-ray radiation, e.g. gamma radiation (A61B6/037 takes precedence)}
- A61B 6/4266: {characterised by using a plurality of detector units (A61B6/4014 takes precedence)}
- A61B 6/4417: {related to combined acquisition of different diagnostic modalities}
- A61B 6/4435: {the source unit and the detector unit being coupled by a rigid structure}
- A61B 6/5247: {combining images from an ionising-radiation diagnostic technique and a non-ionising radiation diagnostic technique, e.g. X-ray and ultrasound}
- A61N 5/1037: {taking into account the movement of the target, e.g. 4D-image based planning}
- A61N 5/1039: {using functional images, e.g. PET or MRI}
- A61N 5/1067: {in real time, i.e. during treatment}
- A61N 5/1077: {Beam delivery systems}
- A61N 5/1082: {having multiple beam rotation axes}
- G01N 23/046: using tomography, e.g. computed tomography [CT]
- G21K 1/093: by magnetic means
- G21K 5/04: with beam-forming means
- A61B 6/0487: {Motor-assisted positioning}
- A61B 6/5205: {involving processing of raw data to produce diagnostic data}
- A61N 5/107: {in real time, i.e. during treatment}
- A61N 2005/105: {using a laser alignment system}
- A61N 2005/1054: {using a portal imaging system}
- A61N 2005/1061: {using an x-ray imaging system having a separate imaging source}
- A61N 2005/1087: {Ions; Protons}
- A61N 2005/1095: {Elements inserted into the radiation path within the system, e.g. filters or wedges}
- A61N 2005/1097: {Means for immobilizing the patient}
- G01N 2223/107: protons
- G01N 2223/203: synchrotron
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G21K: HANDLING OF PARTICLES OR IONISING RADIATION NOT OTHERWISE PROVIDED FOR; IRRADIATION DEVICES; GAMMA RAY OR X-RAY MICROSCOPES

## Abstract

A scintillation material is longitudinally packaged in a circumferentially surrounding sheath, where the sheath has a lower index of refraction than the scintillation material, to form a scintillation optic or scintillation fiber optic. The scintillation material yields secondary photons upon passage of a charged particle beam, such as a positively charged residual particle beam having transmitted through a sample. The internally generated secondary photons within the sheath are guided to a detector element by the difference in index of refraction. Multiple scintillation optics are assembled to form a two-dimensional scintillation array coupled to a two-dimensional detector array, such as for use in determination of state of the residual charged particle beam, determination of an exit point of the particle beam from the sample, path of the treatment beam, and/or tomographic imaging.

## Claims

### Claim 1

A method for tomographic imaging a tumor of a patient with positively charged particles, comprising the steps of:
transporting the positively charged particles along a beam transport line from an accelerator, through the tumor, and to a plurality of scintillation optics, each scintillation optic of said plurality of scintillation optics comprising:
a longitudinal length of a first scintillation material comprising a first index of refraction; and
a cladding circumferentially enclosing said longitudinal length of said first scintillation material, said cladding comprising a second index of refraction, said second index of refraction less than said first index of refraction; and
detecting secondary photons emitted from said first scintillation material, resultant from energy transfer from the positively charged particles, with a two-dimensional detector array optically coupled to a two-dimensional matrix of said plurality of scintillation optics.

### Claim 2 (depends on 1)

The method of claim 1, further comprising the step of:
said cladding comprising said second index of refraction repetitively reflecting a portion of the secondary photons back into said first scintillation material in an optical path to at least one detector element of said two-dimensional detector array.

### Claim 3 (depends on 2)

The method of claim 2, further comprising the steps of:
said step of detecting producing a set of signals;
using said set of signals to determine a vector of the positively charged particles from the patient to said matrix of said plurality of scintillation optics; and
determining an exit area of the positively charged particles from the patient using the vector.

### Claim 4 (depends on 3)

The method of claim 3, further comprising the steps of:
using a first detection sheet positioned in a path of the positively charged particles between said accelerator and the patient to determine an input area of the positively charged particles into the patient; and
probabilistically determining a path of the positively charged particles from the input area to the exit area of the patient.

### Claim 5

The method of Step 4, further comprising the step of:
using a treatment delivery control system, communicatively linked to said accelerator, to approve continued treatment of the tumor using output from the step of probabilistically determining, the output comprising the path of the positively charged particles from the input area to the exit area of the patient.

### Claim 6 (depends on 4)

The method of claim 4, further comprising the step of:
using a second detection sheet positioned in a path of the positively charged particles between the patient and the two-dimensional matrix of said plurality of scintillation optics to determine the exit area of the positively charged particles from the patient.

### Claim 7 (depends on 6)

The method of claim 6, further comprising the steps of:
providing the positively charged particles with an ion source;
providing a triode extraction system, comprising:
said ion source maintained at a first potential;
an extraction electrode maintained at a third potential differing from said first potential; and
a gating electrode positioned between said ion source and said extraction electrode;
alternatingly (1) suppressing extraction of the positively charged particles from said ion source and (2) extracting the positively charged particles from said ion source through changing a second potential of said gating electrode from proximate the first potential to a value between the first potential and the third potential; and
injecting the positively charged particles into said accelerator.

### Claim 8 (depends on 4)

The method of claim 4, further comprising the steps of:
a second scintillation material emitting photons at a second wavelength, at least one of said set of scintillation optics comprising said second scintillation material; and
said secondary photons emitted from said first scintillation material comprising photons at a first wavelength, said second wavelength at least fifty nanometers longer than said first wavelength.

### Claim 9 (depends on 2)

The method of claim 2, further comprising the steps of:
using said first scintillation material, a second scintillation material, and a third scintillation material in an optic of said set of scintillation optics to emit, upon energy transfer from the positively charged particle: (1) a first set of photons comprising a first peak intensity at a first wavelength, (2) a second set of photons comprising a second peak intensity at a second wavelength, and (3) a third set of photons comprising a third peak intensity at a third wavelength, said second wavelength: (1) at least ten nanometers longer than said first wavelength and (2) at least ten nanometers shorter than said third wavelength.

### Claim 10 (depends on 9)

The method of claim 9, further comprising the step of:
determining a residual energy of the positively charged particles after transmitting through the patient using at least one of: said first set of photons, said second set of photons, and said third set of photons.

### Claim 11

An apparatus for tomographic imaging of a tumor of a patient with positively charged particles, comprising:
a beam transport line from an accelerator to a plurality of scintillation optics, each scintillation optic of said plurality of scintillation optics comprising:
a longitudinal length of a first scintillation material comprising a first index of refraction; and
a cladding circumferentially enclosing said longitudinal length of said first scintillation material, said cladding comprising a second index of refraction, said second index of refraction less than said first index of refraction; and
a two-dimensional detector array optically coupled to a two-dimensional matrix of said plurality of scintillation optics, said two-dimensional detector array configured to detect secondary photons emitted from said first scintillation material, resultant from energy transfer from the positively charged particles,
said beam transport line configured to transport the positively charged particles from an accelerator through the tumor to said plurality of scintillation optics during use.

### Claim 12 (depends on 11)

The apparatus of claim 11, further comprising:
a rotational platform configured to: (1) support the patient and said two-dimensional matrix of said plurality of scintillation optics and (2) co-rotate the patient and said two-dimensional matrix of said plurality of scintillation optics during use.

### Claim 13 (depends on 11)

The apparatus of claim 11, further comprising:
a gantry supporting an exit nozzle in a path of the positively charged particles prior to the patient, said gantry configured to co-rotate said exit nozzle with rotation of said two-dimensional matrix of said plurality of scintillation optics.

### Claim 14 (depends on 13)

The apparatus of claim 13, further comprising:
an element of a two-dimensional X-ray imaging system mounted to said gantry, said element of said two-dimensional X-ray imaging system and said two-dimensional matrix of said plurality of scintillation optics configured to co-rotate about the patient with rotation of said gantry.

### Claim 15 (depends on 14)

The apparatus of claim 14, at least one scintillation optic of said plurality of scintillation optics further comprising:
an exit side of said longitudinal length of said first scintillation material; and
an entrance side of a second longitudinal length of a second scintillation material abutted against said exit side of said first scintillation material, said cladding circumferentially surrounding said second longitudinal length of said second scintillation material.

### Claim 16 (depends on 12)

The apparatus of claim 12, further comprising:
a first imaging sheet positioned between the patient and said two-dimensional matrix of said plurality of scintillation optics; and
an imaging system configured to detect first photons emitted from said first imaging sheet, wherein, resultant from transmission of the positively charged particles transmitting through said first imaging sheet, said first imaging sheet emits the first photons.

### Claim 17 (depends on 11)

The apparatus of claim 11, at least one scintillation optic of said plurality of scintillation optics further comprising:
an exit side of said longitudinal length of said first scintillation material; and
an entrance side of a second longitudinal length of a second scintillation material abutted against said exit side of said first scintillation material, said cladding circumferentially surrounding said second longitudinal length of said second scintillation material.

### Claim 18

A method for imaging a sample with positively charged particles, comprising the steps of:
transporting the positively charged particles along a beam transport line from an accelerator, through the sample, and to a plurality of scintillation optics, each scintillation optic of said plurality of scintillation optics comprising:
a longitudinal length of a first scintillation material comprising a first index of refraction; and
a cladding circumferentially enclosing said longitudinal length of said first scintillation material, said cladding comprising a second index of refraction, said second index of refraction less than said first index of refraction; and
detecting secondary photons emitted from said first scintillation material, resultant from energy transfer from the positively charged particles, with a two-dimensional detector array optically coupled to a two-dimensional matrix of said plurality of scintillation optics.

### Claim 19 (depends on 18)

The method of claim 18, further comprising the step of:
rotating a path, relative to the sample, of the positively charged particles passing through the sample; and
collecting a set of images of the sample as a function of said step of rotating.

### Claim 20 (depends on 18)

The method of claim 18, said first scintillation material comprising:
a doped iodide salt.
